The Back-to-School Shot Half of Guys Skip
8 min read · Updated September 2026What HPV actually does
HPV is a family of more than 100 viruses that infect skin and mucous membranes. Most types cause nothing noticeable. A handful cause common warts. About a dozen are called "high-risk" because they can, over years or decades, cause cellular changes that turn into cancer. The virus is so common that it isn't especially useful to think of it as a marker of anything. It's a normal thing sexually active adults acquire, whether through vaginal, anal, or oral sex, and often without any symptoms in either partner.
The relevant question for you isn't whether you'll come into contact with HPV at some point — statistically, you will. The relevant question is whether your body has already been trained to neutralize the specific strains most likely to cause cancer. That training is what the vaccine provides.
The cancers, and who gets them
The CDC's most recent estimates put HPV-caused cancers at about 39,300 per year in the U.S., across roughly 49,900 diagnoses in body parts where HPV commonly infects.[2] The breakdown looks different than it did twenty years ago.
| HPV-caused cancer | Roughly, per year (U.S.) | Who's affected |
|---|---|---|
| Oropharyngeal (throat / back of tongue / tonsils) | ~15,500 in men + ~3,300 in women | Now the most common HPV cancer. ~80% of cases are in men. Case counts have risen ~2.7%/year for decades. |
| Cervical | ~9,700 | Women only. Rates declining thanks to screening + vaccine. |
| Anal | ~4,900 women + ~2,000 men | Rates rising in both. Higher in men who have sex with men and people with HIV. |
| Vulvar / vaginal | ~4,000 | Women only. |
| Penile | ~900 | Rare, but almost entirely HPV-driven when it happens. |
The single most important number for young men in that table is oropharyngeal cancer. The CDC's national trend data show it rose about 2.7% per year in men from 1999 through the mid-2010s and has kept climbing since.[3] As of the most recent AAMC and CDC figures, roughly 18,700 U.S. men and 3,800 women are diagnosed with oropharyngeal cancer each year; HPV drives about 70% of those cases.[4] A generation ago this was mostly a disease of heavy lifetime smokers in their 70s. Today it presents most often in never-smokers in their 40s to 60s. That population was, in almost every case, sexually active in the 1980s and 1990s — before an HPV vaccine existed.
Why this hits male readers hardest
Cervical cancer has a screening test (the Pap smear). Oropharyngeal cancer does not. When it presents, it usually presents late — often as a lump on the side of the neck that the person noticed while shaving. Vaccination is not one prevention tool among several for HPV throat cancer. Right now, it's basically the only one.
Does the vaccine actually work?
Yes, and by an unusually clean margin. The current 9-valent Gardasil 9 vaccine covers the seven high-risk HPV types responsible for roughly 90% of cervical cancers plus two low-risk types that cause 90% of genital warts.[5] Real-world follow-up data from countries that adopted HPV vaccination early — Scotland, Australia, Sweden — are now showing near-elimination of cervical cancer in the first vaccinated birth cohorts. Australia is on track to be the first country to formally eliminate cervical cancer as a public health problem, ahead of schedule.
On the male side of the ledger, the vaccine was FDA-approved for males in 2009 (originally to prevent genital warts and anal cancer) and CDC-recommended for routine boys' vaccination since 2011. It's too early to see the full cancer-prevention data in vaccinated boys — most HPV cancers take 20+ years to develop — but circulating HPV rates and pre-cancerous lesions in vaccinated cohorts have dropped exactly the way they did in girls.
How much of a coverage gap
Every year the CDC publishes the National Immunization Survey-Teen (NIS-Teen), the standard measurement of how many adolescents got which vaccines by age. Some numbers from the most recent data:
- Among adolescents born in 1999 (the first birth cohort with a boys' recommendation available), only 16.9% of boys got at least one HPV dose before age 13 — versus 37.4% of girls.[6]
- By the 2009 birth cohort (kids who turned 13 in 2022), boys had climbed to 65.9% and girls to 73.4%. The gap has narrowed but not closed.[6]
- Nationally, in the 2023 NIS-Teen, 76.8% of adolescents aged 13–17 had initiated the HPV series but only 61.4% were up to date on all recommended doses.[7]
- The largest single reason for missed HPV vaccination was found in the CDC birth-cohort analysis: 82.5% of unvaccinated adolescents had at least one clinic visit where they got another vaccine but not HPV.[6] If those "missed opportunities" had been used, coverage would sit near 95%.
Translation: for the majority of unvaccinated boys, nobody's parents made an ideological decision. The doctor's office didn't bring it up, or brought it up half-heartedly, or gave the other two shots and moved on. That is a fixable situation if you decide to fix it.
Myths that keep getting recycled
MYTH: "That's a girl vaccine."
Recommended for boys since 2011. The most common HPV cancer today, oropharyngeal, is 4× more common in men. HPV also causes anal, penile, and some genital-wart burden that falls on men. The "girl vaccine" framing is a marketing artifact of the vaccine's original 2006 approval for cervical cancer prevention.
TRUTH
Every U.S. medical body — CDC, AAP, AAFP, ACOG — has recommended HPV vaccine for boys routinely since 2011 and for anyone up to age 26 for catch-up (up to 45 in some clinical situations).
MYTH: "If you're not having sex yet, it's too early."
Backwards. It's most effective when given before any exposure. That's why the recommended age is 11 or 12 (with catch-up through 26). It's not about your current sex life; it's about training your immune system before it needs to fight the specific strains.
TRUTH
Younger kids also mount a stronger antibody response — one reason the CDC schedule uses 2 doses under 15 but 3 doses at 15 and older. Earlier is more protection, not less.
MYTH: "I'm too old. Missed the window."
Not exactly. Effectiveness drops with prior exposure, but partial protection is still protection — and if you've already had contact with some HPV strains, the vaccine still covers the ones you haven't seen. FDA-approved through age 45; CDC recommends routine catch-up through 26 and shared decision-making with a doctor from 27 to 45.
TRUTH
If you're between 15 and 26 and not vaccinated, the recommendation is unambiguous: get it. If you're between 27 and 45, ask a doctor whether it makes sense in your specific situation.
MYTH: "Fertility problems."
No credible evidence in nearly two decades of active surveillance. The HPV vaccines are among the most-studied vaccines ever released, with data on more than 270 million doses distributed globally. The Vaccine Safety Datalink, VAERS, and independent studies in the U.S., Europe, and Asia consistently find no association with fertility outcomes in either sex.
TRUTH
The only common side effects are what you get with any injection: sore arm, some redness, occasional low-grade fever or headache. Fainting is more common in adolescents than adults — a reason offices ask you to sit for 15 minutes after.
MYTH: "It'll encourage kids to have sex."
Studied and disproven. Multiple large studies, including a Kaiser Permanente analysis of ~1,400 vaccinated girls vs. matched unvaccinated peers, found no increase in STIs, pregnancy, or contraceptive-seeking behavior post-vaccination.
TRUTH
The kids getting this shot are 11 and 12. They mostly forget about it by the time they matter.
Cost and access, because it matters
For kids and teens through age 18:
- Insurance covers it. The Affordable Care Act designates all ACIP-recommended vaccines, including HPV, as preventive services that must be covered with $0 out-of-pocket cost by non-grandfathered private insurance plans.
- No insurance? The Vaccines for Children (VFC) program provides HPV vaccine at no cost to any child under 19 who is Medicaid-eligible, uninsured, underinsured, or American Indian / Alaska Native. Almost every pediatrician's office and community health center participates.
- Local health departments and Planned Parenthood clinics also provide HPV vaccination, typically on sliding-scale pricing or free through VFC.
For adults 19–45 without insurance, the vaccine list price is roughly $300 per dose (retail), but Merck (the manufacturer) runs a patient assistance program, and county health departments and FQHCs often offer sliding-scale pricing. Some pharmacy chains offer it at cash prices closer to $250 per dose.
The consent question (if you're under 18)
Whether you can get the HPV vaccine without a parent's signature depends on where you live. This is not something we can give you a clean national answer to — the laws vary widely, and they're changing. What we can give you is the honest lay of the land as of 2026:
State-by-state variability
Most states still require parental consent for HPV vaccination of anyone under 18. A minority of states expressly allow minors to consent for themselves — either as a specific carve-out for STI-prevention services (California, New York, and others), through a broader "mature minor" doctrine (Alabama at 14, Oregon at 15, South Carolina at 16), or through case-by-case clinical assessment (Idaho, Washington, and others).[8,9] Local health departments and Planned Parenthood clinics typically know their own state's rules cold. That's a good place to ask.
If you're a minor whose parents oppose the vaccine and you want it, three practical routes:
- Ask a school-based health clinic. Many operate under separate consent rules and can vaccinate on-site.
- Call your county public health department and ask directly: "Under state law, can I consent to my own HPV vaccination?" They will tell you yes or no, and if yes, where.
- Call a Planned Parenthood clinic or FQHC. They know the STI-prevention consent carve-outs cold in every state they operate in.
If none of those work in your state and you're close to 18, the answer may be to wait a few months. If you're 18 or older, none of this applies to you — you consent to your own care.
What "getting the shot" actually looks like
Ages 9–14: two doses, 6–12 months apart
The CDC uses the 2-dose schedule for anyone starting the series before their 15th birthday, because younger kids mount a stronger antibody response. If you got one dose at 12 and never went back, you are not "done" — you need the second, but it doesn't have to be re-started. Just get the next dose whenever.
Ages 15–26: three doses, over 6 months
Standard schedule: dose 2 at 1–2 months, dose 3 at 6 months. Missing a dose deadline doesn't reset anything — you resume where you left off.
Ages 27–45: talk to your doctor
Not routinely recommended, but not against the rules either. If you were unvaccinated and are entering a new relationship situation, changing your sexual behavior, or just want to close the gap, it's a reasonable conversation. Three doses at this age.
The shot itself
Goes in the upper arm muscle. Takes 10 seconds. Sore for a day or two, sometimes low-grade fever, occasionally a headache. You'll be asked to sit for 15 minutes after — this is standard because young people are more likely to faint from any injection. That's the entire experience.
The one-sentence version
This is a vaccine, not a lifestyle statement. It prevents a category of cancer that increasingly kills men, works best if you get it before you need it, and — if you're still in that window — you get to be the one who decides to just do it.
You're allowed to…
- Ask about it at your next physical and expect a straight answer about whether you've had it, when, and whether the series is complete. Your immunization record is yours; you can request it.
- Get the vaccine even if you're already sexually active. The window doesn't close because of your dating history — it just becomes partial protection instead of maximum protection. Partial is still worth a lot.
- Bring it up at the pediatrician's office yourself. "I'd like to catch up on HPV" is a full sentence. Providers who don't push the shot often do give it when the patient asks.
- Consent for yourself in the states that allow it — usually as part of confidential STI-prevention services. Ask your county health department or a Planned Parenthood clinic about your state.
- Get it free through the Vaccines for Children program if you're under 19 and uninsured, underinsured, on Medicaid, or American Indian/Alaska Native.
- Skip the pharmacy small-talk. If a pharmacist or nurse says anything shame-inflected about needing this vaccine, that's on them, not you. Most don't. You're doing an unusually smart thing.
- Ask for the HPV shot at any adult primary-care appointment through age 26 — it's a routine catch-up recommendation, not an unusual request.
Two sentences that get it done
What to say (word for word if you want)
The bottom line
The HPV vaccine prevents nine out of ten HPV-caused cancers. Coverage in U.S. boys has climbed from 17% to 66% in about a decade — real progress, still meaningfully behind girls, and the throat-cancer numbers keep rising in unvaccinated cohorts. If you're between 11 and 26, the answer is almost certainly yes and it costs you nothing under insurance or VFC. If you're between 27 and 45, it might still be worth it — ask a doctor. If you're the parent of an 11-year-old boy: this is one of the shots on the sheet that actually prevents cancer. If you're the 17-year-old about to head off to college: bring it up before you go. If you're the 22-year-old who realizes you never got it: you're inside the window.
Not much in medicine is this simple. Most of it is trade-offs and gray areas. This is a shot that stops a category of cancer. That's the whole conversation.
Sources
- Centers for Disease Control and Prevention. Estimated ~79 million Americans currently infected with HPV; ~90% of men and ~80% of women infected at some point in their lives. HPV is the most common sexually transmitted infection in the U.S.
- CDC. "Cancers Linked with HPV Each Year." Approximately 49,908 new cases of cancer per year in body parts where HPV is often found (27,081 in females, 22,827 in males); HPV causes about 39,300 of these. Oropharyngeal cancers are the most common HPV-associated cancer in men; cervical cancer the most common in women.
- Van Dyne EA, et al. "Trends in Human Papillomavirus–Associated Cancers — United States, 1999–2015." MMWR Morbidity and Mortality Weekly Report 2018;67(33):918–924. Oropharyngeal SCC incidence increased 2.7% per year among men, 0.8% per year among women; cervical carcinoma decreased 1.6% per year over the same period. Oropharyngeal cancer surpassed cervical as the most common HPV-associated cancer.
- Fakhry C, et al., and Association of American Medical Colleges reporting citing National Cancer Institute data (2026): approximately 18,700 U.S. men and 3,800 women diagnosed with oropharyngeal cancer annually; HPV causes about 70% of oropharyngeal cancers in the United States.
- Senkomago V, et al. "Human Papillomavirus–Attributable Cancers — United States, 2012–2016." MMWR 2019;68(33):724–728. Estimated 34,800 cancers per year attributable to HPV, of which 32,100 (92%) were attributable to types targeted by the 9-valent (Gardasil 9) vaccine — 19,000 in females and 13,100 in males; oropharyngeal cancer the most common single type.
- Nyika P, Yankey D, Elam-Evans LD, et al. "Human Papillomavirus Vaccination Coverage Among Adolescent Boys and Girls in the United States: A Birth Year Cohort Analysis of the National Immunization Survey-Teen, 2016–2022." Centers for Disease Control and Prevention. n=131,553 records. HPV coverage before age 13 increased from 27.0% (born 1999) to 69.8% (born 2009); girls 37.4%→73.4%, boys 16.9%→65.9%; 82.5% of unvaccinated adolescents had ≥1 missed vaccination opportunity; achievable coverage would have been ~94.8%.
- Pingali C, Yankey D, Chen M, et al. "National Vaccination Coverage Among Adolescents Aged 13–17 Years — National Immunization Survey-Teen, United States, 2023." MMWR 2024;73(31):708–714. 76.8% of adolescents aged 13–17 had initiated the HPV vaccine; 61.4% were up to date.
- English A, et al. "State Minor Consent Laws: A Summary." Guttmacher Institute state-by-state analyses. Most U.S. states require parental consent for HPV vaccination in minors; several states (California, New York, and others) allow adolescent self-consent as part of STI-prevention services; broader mature-minor authority in Alabama (14), Oregon (15), South Carolina (16), Idaho (case-by-case).
- Weithorn LA, Reiss DR. "Vaccination over Parental Objection — Should Adolescents Be Allowed to Consent to Receiving Vaccines?" New England Journal of Medicine 2018;379(3):205–207. Review of state-by-state consent variability including STI-service carve-outs applicable to HPV vaccination.